Teva: Studies Show Efficacy Of Fremanezumab In Patients With Migraine And Major Depressive Disorder
8/9 08:07
(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA) reported the results of two studies, which demonstrated the efficacy of AJOVY or fremanezumab in migraine patients who also experience depression or anxiety. In the studies, quarterly and monthly dosing of fremanezumab showed...